INSIGHTS ON CLINICAL TRIAL DESIGN

• Faster Trial Planning and Site Selection

  Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.

• Challenges To Making Go/No-Go Decisions In Clinical Trials

  In drug development, a go/no-go decision can be a high-stakes trade-off between speed and certainty. Delve into the real-world operational and strategic hurdles to making those decisions.

• Debunking 5 Misconceptions About Community-Based Research Sites

  By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.

• Leveraging DHTs To Improve Data Collection And Analysis

  How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

• The Renaissance Of Psychedelic Research: History, Protocols, And Forward Trajectories

  7/30/2026

  Discover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.

• Outgrowing Excel: Implementing RTSM In A Live Phase I Trial

  2/25/2026

  Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.

• Adaptive Clinical Trials: Innovation With Hidden Challenges

  5/8/2026

  Adaptive trial designs offer faster results and better patient care, but only if site infrastructure can keep up with the operational complexity of these highly flexible research models.

• DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS

  6/18/2026

  How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?

• The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials

  11/21/2025

  Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.